274 related articles for article (PubMed ID: 22470196)
41. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
42. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
43. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
44. A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.
Besnard-Guérin C; Newsham I; Winqvist R; Cavenee WK
Hum Genet; 1996 Feb; 97(2):163-70. PubMed ID: 8566947
[TBL] [Abstract][Full Text] [Related]
45. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
46. [Wilms' tumors and malformation complexes].
Hata J; Fukuzawa R; Takata A; Kikuchi H
Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
[TBL] [Abstract][Full Text] [Related]
47. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
[TBL] [Abstract][Full Text] [Related]
48. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
49. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
Liu Y; Liu S
Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
[TBL] [Abstract][Full Text] [Related]
50. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
[TBL] [Abstract][Full Text] [Related]
51. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
Karnik P; Chen P; Paris M; Yeger H; Williams BR
Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
[TBL] [Abstract][Full Text] [Related]
52. Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.
El-Kares R; Hueber PA; Blumenkrantz M; Iglesias D; Ma K; Jabado N; Bichet DG; Goodyer P
Pediatr Nephrol; 2009 Jul; 24(7):1313-9. PubMed ID: 19294427
[TBL] [Abstract][Full Text] [Related]
53. The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski C; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Res Sq; 2023 Mar; ():. PubMed ID: 36993649
[TBL] [Abstract][Full Text] [Related]
54. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
55. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
Baird PN; Pritchard J; Cowell JK
Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
[TBL] [Abstract][Full Text] [Related]
56. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
Maiti S; Alam R; Amos CI; Huff V
Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
[TBL] [Abstract][Full Text] [Related]
57. The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes.
Welter N; Brzezinski J; Treece A; Chintagumpala M; Young MD; Perotti D; Kieran K; Jongmans MCJ; Murphy AJ
Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e29984. PubMed ID: 36094328
[TBL] [Abstract][Full Text] [Related]
58. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
Gerald WL; Gramling TS; Sens DA; Garvin AJ
Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
60. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
Feinberg AP
Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
